Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Findings likely to generate hypotheses about potential new uses of drugs
The portfolio includes branded injectable cephalosporines for infectious diseases
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
The freshly infused capital will primarily be deployed towards expansion and research & development
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
Subscribe To Our Newsletter & Stay Updated
